NL9300058A - 1,5-anhydrohexitol nucleoside analoga en farmaceutisch gebruik daarvan. - Google Patents

1,5-anhydrohexitol nucleoside analoga en farmaceutisch gebruik daarvan. Download PDF

Info

Publication number
NL9300058A
NL9300058A NL9300058A NL9300058A NL9300058A NL 9300058 A NL9300058 A NL 9300058A NL 9300058 A NL9300058 A NL 9300058A NL 9300058 A NL9300058 A NL 9300058A NL 9300058 A NL9300058 A NL 9300058A
Authority
NL
Netherlands
Prior art keywords
alkyl
anhydrohexitol
group
nucleoside analogues
formula
Prior art date
Application number
NL9300058A
Other languages
English (en)
Dutch (nl)
Original Assignee
Stichting Rega V Z W
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stichting Rega V Z W filed Critical Stichting Rega V Z W
Publication of NL9300058A publication Critical patent/NL9300058A/nl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
NL9300058A 1992-06-18 1993-01-12 1,5-anhydrohexitol nucleoside analoga en farmaceutisch gebruik daarvan. NL9300058A (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP92201803 1992-06-18
EP92201803 1992-06-18

Publications (1)

Publication Number Publication Date
NL9300058A true NL9300058A (nl) 1994-01-17

Family

ID=8210706

Family Applications (1)

Application Number Title Priority Date Filing Date
NL9300058A NL9300058A (nl) 1992-06-18 1993-01-12 1,5-anhydrohexitol nucleoside analoga en farmaceutisch gebruik daarvan.

Country Status (12)

Country Link
US (2) US5607922A (de)
EP (1) EP0646125B1 (de)
JP (1) JPH08501071A (de)
AT (1) ATE166655T1 (de)
AU (1) AU671129B2 (de)
CA (1) CA2138415A1 (de)
DE (1) DE69318836T2 (de)
DK (1) DK0646125T3 (de)
ES (1) ES2117134T3 (de)
GR (1) GR3027651T3 (de)
NL (1) NL9300058A (de)
WO (1) WO1993025565A1 (de)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06263793A (ja) * 1993-03-04 1994-09-20 Asahi Breweries Ltd ピラノース型ヌクレオシド誘導体
CN1158618A (zh) * 1994-08-17 1997-09-03 雷加Vzw基金会 核酸序列专一性结合寡聚体及其在反义方法中的用途
HUT77436A (hu) * 1994-10-05 1998-04-28 Darwin Discovery Limited Purin- és guaninszármazékok, eljárás előállításukra, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk gyógyszerkészítmények előállítására
AU1874397A (en) * 1996-02-16 1997-09-02 Stichting Rega Vzw Hexitol containing oligonucleotides and their use in antisense strategies
US20040266706A1 (en) * 2002-11-05 2004-12-30 Muthiah Manoharan Cross-linked oligomeric compounds and their use in gene modulation
US20040203024A1 (en) * 1996-06-06 2004-10-14 Baker Brenda F. Modified oligonucleotides for use in RNA interference
US20040171028A1 (en) * 1996-06-06 2004-09-02 Baker Brenda F. Phosphorous-linked oligomeric compounds and their use in gene modulation
US20040171032A1 (en) * 1996-06-06 2004-09-02 Baker Brenda F. Non-phosphorous-linked oligomeric compounds and their use in gene modulation
US20040171030A1 (en) * 1996-06-06 2004-09-02 Baker Brenda F. Oligomeric compounds having modified bases for binding to cytosine and uracil or thymine and their use in gene modulation
US5898031A (en) * 1996-06-06 1999-04-27 Isis Pharmaceuticals, Inc. Oligoribonucleotides for cleaving RNA
US20050042647A1 (en) * 1996-06-06 2005-02-24 Baker Brenda F. Phosphorous-linked oligomeric compounds and their use in gene modulation
US7812149B2 (en) * 1996-06-06 2010-10-12 Isis Pharmaceuticals, Inc. 2′-Fluoro substituted oligomeric compounds and compositions for use in gene modulations
WO2005121370A2 (en) * 2004-06-03 2005-12-22 Isis Pharmaceuticals, Inc. Oligomeric compounds that facilitate risc loading
US20040161844A1 (en) * 1996-06-06 2004-08-19 Baker Brenda F. Sugar and backbone-surrogate-containing oligomeric compounds and compositions for use in gene modulation
US20050118605A9 (en) * 1996-06-06 2005-06-02 Baker Brenda F. Oligomeric compounds having modified bases for binding to adenine and guanine and their use in gene modulation
US20040161777A1 (en) * 1996-06-06 2004-08-19 Baker Brenda F. Modified oligonucleotides for use in RNA interference
US9096636B2 (en) * 1996-06-06 2015-08-04 Isis Pharmaceuticals, Inc. Chimeric oligomeric compounds and their use in gene modulation
US20050053976A1 (en) * 1996-06-06 2005-03-10 Baker Brenda F. Chimeric oligomeric compounds and their use in gene modulation
DE60011787T2 (de) * 1999-09-10 2005-07-14 Stichting Rega V.Z.W. Carbocyclische nukleoside und verfahren zu deren herstellung
US7138531B2 (en) * 2001-10-15 2006-11-21 Kemin Pharma B.V.B.A. Preparation and use of carbohydrate-based bicyclic ring structures with antimicrobial and cytostatic activity
US9150605B2 (en) 2002-11-05 2015-10-06 Isis Pharmaceuticals, Inc. Compositions comprising alternating 2′-modified nucleosides for use in gene modulation
AU2003291753B2 (en) * 2002-11-05 2010-07-08 Isis Pharmaceuticals, Inc. Polycyclic sugar surrogate-containing oligomeric compounds and compositions for use in gene modulation
AU2003287502B2 (en) * 2002-11-05 2010-12-09 Isis Pharmaceuticals, Inc. Compositions comprising alternating 2'-modified nucleosides for use in gene modulation
US9150606B2 (en) * 2002-11-05 2015-10-06 Isis Pharmaceuticals, Inc. Compositions comprising alternating 2'-modified nucleosides for use in gene modulation
US7560231B2 (en) 2002-12-20 2009-07-14 Roche Molecular Systems, Inc. Mannitol and glucitol derivatives
CA2463719A1 (en) * 2003-04-05 2004-10-05 F. Hoffmann-La Roche Ag Nucleotide analogs with six membered rings
EP1636342A4 (de) * 2003-06-20 2008-10-08 Isis Pharmaceuticals Inc Oligomere verbindungen zur verwendung bei der modulation von genen
US8569474B2 (en) * 2004-03-09 2013-10-29 Isis Pharmaceuticals, Inc. Double stranded constructs comprising one or more short strands hybridized to a longer strand
US8394947B2 (en) * 2004-06-03 2013-03-12 Isis Pharmaceuticals, Inc. Positionally modified siRNA constructs
US7884086B2 (en) * 2004-09-08 2011-02-08 Isis Pharmaceuticals, Inc. Conjugates for use in hepatocyte free uptake assays
AU2007211080B9 (en) 2006-01-27 2012-05-03 Isis Pharmaceuticals, Inc. 6-modified bicyclic nucleic acid analogs
AU2007257094B2 (en) * 2006-05-05 2012-10-25 Isis Pharmaceuticals, Inc. Compounds and methods for modulating expression of SGLT2
US7666854B2 (en) * 2006-05-11 2010-02-23 Isis Pharmaceuticals, Inc. Bis-modified bicyclic nucleic acid analogs
US7547684B2 (en) * 2006-05-11 2009-06-16 Isis Pharmaceuticals, Inc. 5′-modified bicyclic nucleic acid analogs
AU2008286771B2 (en) 2007-08-15 2013-08-15 Isis Pharmaceuticals, Inc. Tetrahydropyran nucleic acid analogs
WO2009100320A2 (en) * 2008-02-07 2009-08-13 Isis Pharmaceuticals, Inc. Bicyclic cyclohexitol nucleic acid analogs
US20120021515A1 (en) 2009-02-06 2012-01-26 Swayze Eric E Oligomeric compounds and methods
WO2010090969A1 (en) 2009-02-06 2010-08-12 Isis Pharmaceuticals, Inc. Tetrahydropyran nucleic acid analogs
US8496917B2 (en) * 2009-11-13 2013-07-30 Sytheon Ltd Compositions and methods for improving skin appearance
US8993738B2 (en) 2010-04-28 2015-03-31 Isis Pharmaceuticals, Inc. Modified nucleosides, analogs thereof and oligomeric compounds prepared therefrom
JP6129844B2 (ja) 2011-09-14 2017-05-17 ラナ セラピューティクス インコーポレイテッド 多量体オリゴヌクレオチド化合物
DK3137476T3 (da) 2014-04-28 2019-11-18 Ionis Pharmaceuticals Inc Linker-modificerede oligomerforbindelser

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK167377B1 (da) * 1985-09-17 1993-10-25 Wellcome Found 3'-azidopyrimidinnucleosider eller farmaceutisk acceptable salte eller estere deraf til anvendelse ved behandling af eller profylakse for en human retrovirusinfektion
US4997926A (en) * 1987-11-18 1991-03-05 Scripps Clinic And Research Foundation Deaminase-stable anti-retroviral 2-halo-2',3'-dideoxy
SE8802687D0 (sv) * 1988-07-20 1988-07-20 Astra Ab Nucleoside derivatives
DD293498A5 (de) * 1989-07-20 1991-09-05 Zi Fuer Molekularbiologie Der Adw,De Verfahren zur herstellung eines mittels fuer die behandlung oder prophylaxe von hepatits-infektionen bei mensch und tier

Also Published As

Publication number Publication date
DK0646125T3 (da) 1999-03-22
AU4301393A (en) 1994-01-04
US5668113A (en) 1997-09-16
EP0646125B1 (de) 1998-05-27
EP0646125A1 (de) 1995-04-05
DE69318836T2 (de) 1999-01-28
US5607922A (en) 1997-03-04
ATE166655T1 (de) 1998-06-15
JPH08501071A (ja) 1996-02-06
GR3027651T3 (en) 1998-11-30
WO1993025565A1 (en) 1993-12-23
CA2138415A1 (en) 1993-12-23
AU671129B2 (en) 1996-08-15
DE69318836D1 (de) 1998-07-02
ES2117134T3 (es) 1998-08-01

Similar Documents

Publication Publication Date Title
NL9300058A (nl) 1,5-anhydrohexitol nucleoside analoga en farmaceutisch gebruik daarvan.
EP0243670B1 (de) Purin- und Pyrimidin-Verbindungen und deren Verwendung als Antivirusmittel
US6833361B2 (en) Nucleosides having bicyclic sugar moiety
Martin et al. Synthesis and antiviral activity of monofluoro and difluoro analogs of pyrimidine deoxyribonucleosides against human immunodeficiency virus (HIV-1)
Verheggen et al. Synthesis and antiherpes virus activity of 1, 5-anhydrohexitol nucleosides
AU613026B2 (en) 2',3' dideoxyribofuranoxide derivatives
DE60005502T2 (de) 4'-c-ethynyl-purin-nukleoside
JPH0723394B2 (ja) 新規アデノシン誘導体及び該化合物を有効成分として含有する医薬組成物
HU203363B (en) Process for producing 2',3'-dideoxy-2',2'-difluoronucleosides and pharmaceutical compositions comprising same as active ingredient
CA2085345C (en) Pyrimidine nucleoside derivatives
GB2260319A (en) Nucleoside ester antiviral agents
GB2125401A (en) Desoxyuridine derivatives and their use as pharmaceuticals
Manta et al. Synthesis of 4, 6-dideoxy-3-fluoro-2-keto-β-D-glucopyranosyl analogues of 5-fluorouracil, N6-benzoyl adenine, uracil, thymine, N4-benzoyl cytosine and evaluation of their antitumor activities
JP6767011B2 (ja) 抗ｄｎａウィルス活性などの生理活性を有するヌクレオシド誘導体
DE60204859T2 (de) Verfahren zur Herstellung von 2'-Halo-beta-L-arabino-furanosylnucleosiden
JPS6310787A (ja) ヌクレオシド類縁体、その製造法および抗ウイルス剤
Kumar et al. Synthesis of 5-[1-hydroxy (or methoxy)-2-bromo (or chloro) ethyl]-2'-deoxyuridines and related halohydrin analogs with antiviral and cytotoxic activity
US5644043A (en) 2',3'-dideoxy-2',2'-difluoronucleosides and intermediates
US5817639A (en) Purine 4'-thioarabinonucleosides
US5126347A (en) Isomeric dideoxynuclesides
JP6983814B2 (ja) 抗ウイルス活性を示すヌクレオシド誘導体
US5457091A (en) N1-substituted 1H-1,2,3-triazolo[4,5,-D]pyrimidines, a process for their preparation and their use as antiviral agents
EP0617046A1 (de) Nucleosidderivate und Antiherpes-Zusammensetzung
EP0095292A1 (de) 5-(2-Halovinyl)-2'-deoxyuridin-Derivate, Verfahren zu ihrer Herstellung, sie enthaltende pharmazeutische Zusammensetzungen und ihre Anwendung bei der Behandlung von viralen Infektionen
JPH05178746A (ja) 抗ウイルス剤

Legal Events

Date Code Title Description
A1B A search report has been drawn up
BV The patent application has lapsed